MYX 3.29% $4.40 mayne pharma group limited

Is MYX a bargain, page-1079

  1. 525 Posts.
    lightbulb Created with Sketch. 160
    Investor relations said the FDA inspected both Mithra's drug and device sites last year as part of the original Nuvaring submission. I believe the complete response letter was all about more bio-eq data. So would assume another site inspection is not required?
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.